Market Overview

UPDATE: Bank of America Reduces PO to $43 on LifePoint Hospitals Post Weak Quarter

Related LPNT
Top 4 Mid-Cap Stocks In The Hospitals Industry With The Highest EPS Growth Forecast For Next Year
Earnings Scheduled For July 31, 2015

Bank of America reiterated its Neutral rating on LifePoint Hospitals (NASDAQ: LPNT) and reduced its price objective from $46 to $43.

Bank of America commented, "Q3 was disappointing on a number of fronts and even adjusting for all the items LPNT claims as 1x, normalized EBITDA was 11% below consensus, with guidance implying a similar reduction in Q4. … With no formal guidance from the company yet, we estimate 2013 EBITDA could be $572-$602m, up 7-11% y/y. After analyzing the puts and takes, we feel comfortable above the midpoint of that range, but it still marks a reduction vs. our prior est of $636m and our visibility in LPNT's operations is clearly lower after this quarter. We are reducing our 2012/13/14 EPS ests to $3.14/$3.51/$4.42 from $3.59/$3.77/$4.54 and cutting our PO to $43 from $46."

LifePoint Hospitals closed at $36,16 on Friday.

Latest Ratings for LPNT

Sep 2015JP MorganInitiates Coverage onNeutral
Aug 2015Cantor FitzgeraldMaintainsHold
Aug 2015BarclaysMaintainsUnderweight

View More Analyst Ratings for LPNT
View the Latest Analyst Ratings

Posted-In: Bank of AmericaAnalyst Color Price Target Intraday Update Analyst Ratings


Related Articles (LPNT)

View Comments and Join the Discussion!

Get Benzinga's Newsletters